Brexit: first aid for Pharma
19 July 2016
Industries: Life Sciences and Healthcare
Services: Administrative and Public Law, Government Relations and Policy Advocacy, Intellectual Property, Medical Device Law, Patents, Pharmaceutical and Biotechnology Regulatory Law
Brexit, if and when it happens, may have a substantial impact on the UK pharmaceutical industry. Although related issues will also have an impact upon many aspects of that industry, this note focuses on the key regulatory implications.
"First Aid for Pharma" focuses on UK pharmaceutical companies that wish to continue to operate within the EU structure in a post-Brexit world.
Find out more here.